HomeCMPX • NASDAQ
add
Compass Therapeutics Inc.
Previous close
$1.85
Day range
$1.80 - $1.87
Year range
$0.77 - $2.33
Market cap
251.79M USD
Avg Volume
473.67K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 850.00K | — |
Operating expense | 15.90M | 19.18% |
Net income | -13.08M | -15.94% |
Net profit margin | -1.54K | — |
Earnings per share | -0.10 | -11.11% |
EBITDA | -14.89M | -13.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 146.23M | -13.35% |
Total assets | 155.61M | -13.15% |
Total liabilities | 9.51M | -12.74% |
Total equity | 146.10M | — |
Shares outstanding | 137.59M | — |
Price to book | 1.75 | — |
Return on assets | -23.75% | — |
Return on capital | -24.61% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -13.08M | -15.94% |
Cash from operations | -10.75M | -6.34% |
Cash from investing | 6.48M | 1,071.96% |
Cash from financing | 1.00K | -99.97% |
Net change in cash | -4.27M | 44.90% |
Free cash flow | -6.03M | -3.09% |
About
Founded
2014
Headquarters
Website
Employees
32